Cover Image
市場調查報告書

生物性骨材的全球市場的未來展望

Global Orthobiologics Market Outlook 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 356647
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
生物性骨材的全球市場的未來展望 Global Orthobiologics Market Outlook 2020
出版日期: 2016年04月01日 內容資訊: 英文 120 Pages
簡介

所謂生物性骨材 (orthobiologics) ,是指使用人體來源、天然材料的整形外科治療。由於治癒、回復速度快,及住院日數變短,現在需求急速擴大,在各種領域活用。2015年時,全球生物性骨材的市場規模估計約40億美元。關節炎等整形外科疾病的患病人數增加,及老年人口的增加,肥胖症的擴大等,成為市場成長的主要原因。另一方面,治療成本高和複雜的法規結構,骨形成蛋白 (BMP) 的生物適性的問題等,有妨礙市場成長的可能性。

本報告提供全球生物性骨材市場相關分析,市場、產品概要,及主要推動及阻礙市場要素,關於各產品種類、各用途、各地區的市場趨勢預測 (今後6年份),市場競爭概況,主要企業簡介、最新形勢等調查評估。

第1章 分析師的見解

第2章 分析方法

第3章 生物性骨材:概要

第4章 市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場趨勢

第5章 全球生物性骨材市場未來展望 (到2020年)

第6章 全球生物性骨材市場:各產品種類的市場規模

  • 骨形成蛋白 (BMP)
  • 去礦物質骨基質 (DBM)
  • 人工骨替代材料
  • 同種骨移植片
  • 幹細胞療法
  • 機器加工骨
  • 關節內補充藥

第7章 全球生物性骨材市場:各用途的市場規模

  • 脊椎融合手術
  • 重組手術
  • 外傷手術

第8章 全球生物性骨材市場:各地區的市場規模

  • 北美
  • 歐洲
  • 亞洲
  • 其他的國家 (RoW)

第9章 開發平台分析

第10章 競爭環境

第11章 主要企業分析

  • Zimmer Biomet
  • Stryker Corporation
  • DePuy Synthes, Inc. (Johnson & Johnson的子公司)
  • Medtronic plc
  • Smith & Nephew Plc
  • Orthofix International N.V
  • Wright Medical Group N.V
  • Integra Life Sciences Corporation
  • NuVasive, Inc.
  • Globus Medical, Inc.
目錄

Orthobiologics finds extensive application in various orthopedic diseases treatment. The orthobiologics are made utilizing substances found naturally in the human body. These products are increasing in demand as they provide quick healing, faster recovery, and lesser number of hospital visits.

According to RNCOS' new research report "Global Orthobiologics Market Outlook 2020", the orthobiologics market was valued around US$ 4 Billion in 2015. The major reason for the growth of the market is the increasing adoption of orthobiologics, especially bone graft substitutes in different orthopedic applications. In addition, rise in the incidence of arthritis and other orthopedic diseases, increase in geriatric population and increase in obesity rate has triggered the growth of this market. However, factors such as high cost of the orthobiologics and orthopedic procedures, complex regulatory framework, and the biocompatibility issues associated with bone morphogenetic proteins are expected to hamper the market growth in the forecasted period.

RNCOS, in its report has segmented the global orthobiologics market on the basis of product type, application, and geography. Viscosupplementation accounts for the largest share of the orthobiologics products market. Synthetic bone substitutes and stem cell based products are expected to witness a significant growth due to increasing number of research related activities in the stem cell orthobiologics market. Furthermore, the report also provides insights about the orthobiologics products that are in developmental stages.

Based on applications, the orthobiologics market is divided into spinal fusion, trauma and reconstructive surgery. Spinal fusion accounted for the largest share of the market owing to increasing number of spinal fusion surgeries. The reconstructive surgery market is poised to witness highest growth due to rising number of hip and knee replacement surgeries.

The market has been divided into four major regions to provide a regional analysis of the orthobiologics market: North America, Europe, Asia, and Rest of the World. Of these, North America is currently the largest market for orthobiologics owing to a high prevalence of obesity and arthritis, and higher healthcare expenditure in the region. The high share is also attributed to the wide acceptance of orthobiologics products, coupled with launch of new and advanced products in the market. The Asian market is poised to witness the highest growth in the forecasted period due to increasing focus of players in this region, and also as a result of an expanding geriatric population base and increasing number of road accidents.

After an exhaustive study of the industry, the report presents a deep dive competitive landscape covering the top players along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Zimmer Biomet, Medtronic plc, Stryker Corporation, DePuy Synthes, Inc., Smith & Nephew plc, and Wright Medical Group N.V. are some of the leading players in the global orthobiologics market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Orthobiologics: An Introduction

4. Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Growing Geriatric Population
    • 4.1.2 Surge in the Number of Orthopedic Surgeries
    • 4.1.3 Rampant Usage of Bone Grafts Substitutes in Various Applications
    • 4.1.4 Growing Usage of Biologic Solutions in Sports Medicine
    • 4.1.5 Increasing Acceptance of Orthobiological Products
    • 4.1.6 Rising Incidence of Obesity and Orthopedic Diseases
    • 4.1.7 Technological Advancements
  • 4.2 Market Restraints
    • 4.2.1 High cost of Orthobiologics and Orthopedic procedures
    • 4.2.2 Less-Defined Regulatory Environment
    • 4.2.3 Biocompatibility Issues
    • 4.2.4 Lack of Clinical Data
  • 4.3 Market Opportunities
    • 4.3.1 Rising Orthobiologics Utility in Fracture Healing
    • 4.3.2 Bone Grafts and Substitutes Offers Significant Growth Opportunity
    • 4.3.3 High Growth Asian Market
  • 4.4 Market Trends
    • 4.4.1 Growing Interest of Venture Capitalist Firms In Orthobiologics
    • 4.4.2 Rise in Strategic Alliances in Orthobiologics Market
    • 4.4.3 Soft Tissue Repair: Gaining Momentum

5. Global Orthobiologics Market Outlook to 2020

6. Global Orthobiologics Market Size by Product Type

  • 6.1 Bone Morphogenetic Proteins (BMP)
  • 6.2 Demineralized Bone Matrix (DBM)
  • 6.3 Synthetic Bone Substitutes
  • 6.4 Bone Allografts
  • 6.5 Stem Cell Therapy
  • 6.6 Machined Bones
  • 6.7 Viscosupplementation

7. Global Orthobiologics Market Size by Applications

  • 7.1 Spinal Fusion Surgery
  • 7.2 Reconstructive Surgery
  • 7.3 Trauma Surgery

8. Global Orthobiologics Market Size by Geography

  • 8.1 North America
  • 8.2 Europe
  • 8.3 Asia
  • 8.4 Rest of the World (RoW)

9. Pipeline Analysis

10. Competitive Landscape

11. Key Player Analysis

  • 11.1 Zimmer Biomet
  • 11.2 Stryker Corporation
  • 11.3 DePuy Synthes, Inc. (A Subsidiary of Johnson & Johnson)
  • 11.4 Medtronic plc
  • 11.5 Smith & Nephew Plc
  • 11.6 Orthofix International N.V
  • 11.7 Wright Medical Group N.V
  • 11.8 Integra Life Sciences Corporation
  • 11.9 NuVasive, Inc.
  • 11.10 Globus Medical, Inc.

List of Figures:

  • Figure 4-1: Global - Population above 60 Years (Billion), 2013 & 2050
  • Figure 5-1: Global - Orthobiologics Market (Million US$), 2015-2020
  • Figure 6-1: Global - Orthobiologics Market by Product Type (%), 2015
  • Figure 6-2: Global - Orthobiologics Market by Product Type (%), 2020
  • Figure 6-3: Global - Orthobiologics Market for Bone Morphogenetic Proteins (Million US$), 2015-2020
  • Figure 6-4: Global - Orthobiologics Market for Demineralized Bone Matrix (Million US$), 2015-2020
  • Figure 6-5: Global - Orthobiologics Market for Synthetic Bone Substitutes (Million US$), 2015-2020
  • Figure 6-6: Global - Orthobiologics Market for Bone Allografts (Million US$), 2015-2020
  • Figure 6-7: Global - Orthobiologics Market for Stem Cell Therapy (Million US$), 2015-2020
  • Figure 6-8: Global - Orthobiologics Market for Machined Bones (Million US$), 2015-2020
  • Figure 6-9: Global - Orthobiologics Market for Viscosupplementation (Million US$), 2015-2020
  • Figure 7-1: Global - Orthobiologics Market by Application (%), 2015
  • Figure 7-2: Global - Orthobiologics Market by Application (%), 2020
  • Figure 7-3: Global - Orthobiologics Spinal Fusion Surgery Market (Million US$), 2015-2020
  • Figure 7-4: Global - Orthobiologics Reconstructive Surgery Market (Million US$), 2015-2020
  • Figure 7-5: Global - Orthobiologics Trauma Surgery Market (Million US$), 2015-2020
  • Figure 8-1: Global - Orthobiologics Market by Geography (%), 2015
  • Figure 8-2: Global - Orthobiologics Market by Geography (%), 2020
  • Figure 8-3: North America - Orthobiologics Market (Million US$), 2015-2020
  • Figure 8-4: Europe - Orthobiologics Market (Million US$), 2015-2020
  • Figure 8-5: Asia - Orthobiologics Market (Million US$), 2015-2020
  • Figure 8-6: Rest of the World - Orthobiologics Market (Million US$), 2015-2020
  • Figure 10-1: Global - Share of Major Players in Orthobiologics Market (%), 2015
  • Figure 11-1: Zimmer Biomet - Breakup of Revenue by Region (%), 2015
  • Figure 11-2: Stryker Corporation - Breakup of Revenue by Region (%), 2015
  • Figure 11-3: Johnson & Johnson - Breakup of Revenue by Region (%), 2015
  • Figure 11-4: Medtronic plc - Breakup of Revenue by Region (%), 2015
  • Figure 11-5: Smith & Nephew plc - Breakup of Revenue by Region (%), 2015
  • Figure 11-6: Orthofix International N.V. - Breakup of Revenue by Region (%), 2015
  • Figure 11-7: Wright Medical Group N.V. - Breakup of Revenue by Region (%), 2015
  • Figure 11-8: Integra Life Sciences Corporation - Breakup of Revenue by Region (%), 2014
  • Figure 11-9: NuVasive, Inc. - Breakup of Revenue by Region (%), 2014
  • Figure 11-10: Globus Medical, Inc. - Breakup of Revenue by Region (%), 2015

List of Tables:

  • Table 4-1: Global - Venture Capitalist Investments (Million US$), 2012-2015
  • Table 4-2: Global - Mergers & Acquisitions
  • Table 4-3: Soft Tissue Repair/Replacement Product Landscape
  • Table 9-1: Global - Orthobiologics Products Pipeline
  • Table 11-1: Zimmer Biomet - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-2: Zimmer Biomet - Product Portfolio for Orthobiologics Market
  • Table 11-3: Stryker Corporation - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-4: Stryker Corporation - Product Portfolio for Orthobiologics Market
  • Table 11-5: Johnson & Johnson - Medical Devices Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-6: Johnson & Johnson - Product Portfolio for Orthobiologics Market
  • Table 11-7: Medtronic plc - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-8: Medtronic plc - Product Portfolio for Orthobiologics Market
  • Table 11-9: Smith & Nephew plc - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-10: Smith & Nephew plc - Product Portfolio for Orthobiologics Market
  • Table 11-11: Orthofix International N.V. - Revenue by Product Segment (Million US$),2013-2015
  • Table 11-12: Orthofix International N.V. - Product Portfolio for Orthobiologics Market
  • Table 11-13: Wright Medical Group N.V. - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-14: Wright Medical Group N.V. - Product Portfolio of Biologics for Orthobiologics Market
  • Table 11-15: Integra Life Sciences Corporation - Revenue by Product Segment (Million US$),2012-2014
  • Table 11-16: Integra Life Sciences Corporation - Product Portfolio for Orthobiologics Market
  • Table 11-17: NuVasive, Inc. - Revenue by Product Segment (Million US$), 2012-2014
  • Table 11-18: NuVasive, Inc. - Product Portfolio for Orthobiologics Market
  • Table 11-19: Globus Medical, Inc. - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-20: Globus Medical Inc. - Product Portfolio for Orthobiologics Market
Back to Top